Wastewater Drug Indicator Evaluation on the United States Southern Border
Closed Posted
- Opportunity number
- WDE-WDE-24-001
- Agency
-
Office of the National Drug Control Policy
Executive Office of the President
- Applications due
- Award size
- Up to $300,000
Opportunity facts
- Assistance listings
-
- 95.007 Research and Data Analysis
- Funding instrument
- Cooperative Agreement
- Category
-
- Health
- Eligible applicants
-
- Higher Education Inst. (Public)
- Non-501(c)(3) Nonprofits
- Higher Education Inst. (Private)
- 501(c)(3) Nonprofits
- Full announcement
Opportunity details come from Grants.gov. Updated .
About this opportunity
The Federal Grant Opportunity ID 356111-F, titled "Wastewater Drug Indicator Evaluation on the United States Southern Border," is seeking applicants to conduct research and data analysis on wastewater-based epidemiology (WBE) as a tool for monitoring drug consumption patterns and emerging drug threats along the U.S. southern border. The funding is provided by the Executive Office of the President Office of the National Drug Control Policy under the Research and Data Analysis program (CFDA 95.007). Eligible applicant types include higher education institutions, non-501(c)(3) nonprofits, and 501(c)(3) nonprofits. The key objectives are to expand the use of WBE to track drug usage trends and identify novel substances in communities along the southern border. The evaluation criteria will likely focus on the applicant's expertise in WBE, their proposed methodology, and the potential impact of the research. The application deadline is September 3, 2024.
Recent Federal Grant Awards under this program have ranged from $100,000 to $3,000,000, typically for 12-month project periods. The place of performance is expected to be along the U.S. southern border, as the goal is to monitor drug indicators in those communities.
Synopsis
Wastewater Based Epidemiology involves analyzing the chemical and biological components present in wastewater to gather information about the health and behavior of a population. Localities have used it to monitor drug consumption patterns in their communities and understand local drug usage trends. It holds promise for monitoring the emergence and geographic distribution of novel substances often referred to as emerging threats. In FY2023, the United States Government funded pilot WBE drug projects that collected wastewater samples in over 70 United States communities representing tens of millions of Americans. The samples were analyzed for parent drugs, such as fentanyl and methamphetamine, and metabolites. Researchers shared results with participating sampled communities, local and state partners, and to a limited extent, the government sponsors.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity